Bicarbonate for In-Hospital Cardiac Arrest
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 778 participants.
Also called NCT05564130
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 778 participants
- Registry
-
NCT05564130
-
- Other papers using this trial's data
- Sodium Bicarbonate for In-Hospital Cardiac Arrest: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05564130. Randomized; quadruple masking; primary purpose treatment. Start 2023-02-06 (actual); primary completion 2026-02-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bicarbonate for In-Hospital Cardiac Arrest
- Acronym
- BIHCA
- Condition
- Cardiac Arrest
- Intervention (Drug)
- Sodium bicarbonate
- Intervention (Drug)
- Sodium chloride
- Lead sponsor
- Lars Wiuff Andersen
- Collaborator
- University of Aarhus
Record details
- Record id
cardio:ct-nct05564130- Content hash
04fd15d69e893ac91edb4e65a0a4715b397d00185597b29a920570c133c2ae03